David Siffert, legal director at S.T.O.P., discusses 23andMe’s possible bankruptcy along with the potential legal fallout and ...

Vertical farms, woke AI, and 23andMe made our annual list of failed tech. They say you learn more from failure than success.

Thomson Reuters will pay out a $27.5 million settlement to people whose information was exposed by its Clear AI product, but ...

Verdict: False The audio is AI generated and there is no proof that the two events are related in any way. Fact Check: ...

Amy Nordrum, executive editor, and Charlotte Jee, news editor. Each year, MIT Technology Review publishes an annual list of ...

As AI advances genomic analyses, the potential for misuse grows, amplifying risks of discrimination and exploitation that could span generations. 23andMe’s struggles demonstrate that the ...

It remains unknown how many patients are affected by the incident. The Qilin ransomware group claims to have leaked 400 ...

Just over a year ago, 23andMe’s co-founder and CEO Anne Wojcicki was assuring the life sciences industry that the company was a “full-fledged biotech” committed to drug R&D. “We have real ...

23andMe, a major company providing direct-to-consumer genetic testing, has been struggling financially since late 2023. In September 2024, the company's stock hit a rock-bottom of US$0.30, down 96 ...

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping job losses. The company that made its name by providing saliva ...

Two of the most popular brands are Ancestry and 23andMe. To learn more, we outlined the pros, cons and factors to consider. However, since this comparison was first published, 23andMe has ...

As AI advances genomic analyses, the potential for misuse grows, amplifying risks of discrimination and exploitation that could span generations. 23andMe’s struggles demonstrate that the ...